glp-1 prevent diabetes The Agonists and Obesity: How Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Semaglutide Shows Secondary Cardiovascular Prevention

Michalec K, Mysiorek C, Kuntz M, Brzowski V, Szczepankiewicz AA, Wilczyski GM, et al

As supply chains scale to meet this demand, the industrys ability to protect product integrity at every stage of transport will matter not just operationally and financially, but to the patients at the end of the chain

Weight loss begins but may be modest, averaging 2-4 pounds depending on starting weight and dose

An analysis of insurance claims for GLP-1 weight-loss therapy (in patients without diabetes) found only 29% were still on the medication at 1 year, and a mere 15% at 2 years (source)

Burns Fat and Increases energy levels